30IG

iShares iBonds Dec 2030 Term € Corp UCITS ETF EUR (Dist)

ETFs & Funds · EUR · XETRA

30IGETFT212

Price

€5.135

+0.23%

Cap

Earnings

30d Trend

+0.8%

30IG
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityLow

4% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level15
Momentum52
Technical49
Fund Quality76
Cost Efficiency68

Raw weighted: 65×Macro 0.99 (1%)=64

RISK

15/100
90d Volatility
4.4%Low
ATR %
0.4%Low daily moves
Max Drawdown (1Y)
-2.1%Resilient

MOMENTUM

52/100
12-1M Momentum
+2.1%Uptrend
6-1M Momentum
+0.2%Flat
1M Return
+0.5%Stable

TECHNICAL

49/100
RSI (14)
56.0Neutral
Price vs SMA200
+0.9%Flat
MACD
+0.01Bullish momentum
Bollinger Band
73%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.139Noisy/choppy

FUND QUALITY

76/100
Replication
PhysicalHolds actual assets
Holdings
732 positionsHighly diversified
Domicile
Ireland (tax-efficient)15% US withholding tax
Yield
3.73% (Distributing)High income

COST EFFICIENCY

68/100
Expense Ratio
0.12%Low cost
Fund Size (AUM)
$150MSmall

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months41
3-12 months54
1-5+ years68

Long-term compounder — quality business with growth runway

BRAIN47'S ASSESSMENT

I rate iShares iBonds Dec 2030 Term € Corp UCITS ETF EUR (Dist) at 64/100 — a STRONG reading on the Brain47 Signal. The strongest factor is risk management at 85/100. I classify this as a defensive position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

+0.5%

3 MONTHS

-0.2%

12 MONTHS

+2.6%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder — quality business with growth runway. low-risk profile and Fund Quality (76) are the primary strengths. Historical volatility is low at 4%. I classify this as a defensive holding — low volatility and high business quality provide portfolio ballast.

defensiveScore: 64/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.